The world’s first robotic-assisted implantation of an artificial heart pump was successfully performed at King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh.
The surgery was conducted on a 35-year-old patient who had been hospitalized for 120 days due to advanced heart failure, which had caused significant kidney and lung function deterioration.
This groundbreaking procedure involved the implantation of the HeartMate 3, a state-of-the-art device developed by Abbott, and represents a major leap forward in medical technology and patient care.
The operation was led by Dr. Feras Khaliel, head of cardiac surgery and director of KFSHRC’s Robotics and Minimally Invasive Surgery Program.
The patient’s recovery has been remarkably swift. He spent only four days in the intensive care unit—compared to the typical 26-day average for similar procedures using conventional methods. His total recovery time is also expected to be drastically reduced, with discharge anticipated within 10 days instead of the usual 63.
Dr. Bjorn Zoega, deputy CEO of KFSHRC, described the achievement as a testament to the hospital’s commitment to innovation and safety, saying “This milestone showcases our ability to deliver groundbreaking medical solutions while upholding rigorous safety standards, redefining the future of healthcare.”
